Evidence map›Paper›PMID 33948025›Full record

ReviewNature reviews. Gastroenterology & hepatology2021

The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

Seppo Salminen, Maria Carmen Collado, Akihito Endo, Colin Hill, Sarah Lebeer, Eamonn M M Quigley, Mary Ellen Sanders, Raanan Shamir, Jonathan R Swann, Hania Szajewska and 1 more

Erratum issued 6 registry-linked trialsAbstract readConsensus StatementReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 6 registered trials, which are not on this map. Cited by 1,208 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,208citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05164692 nacompletednot on this map

Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Respiratory Syncytial Virus

TypeinterventionalSponsorNational Children's Hospital, VietnamRan2020 to 2021Enrolled100ConditionsAcute Respiratory Tract InfectionsArmsLiveSpo Navax, 0.9% NaCl physiological saline
NCT06268964 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Comparative Effect of Trimebutine and Probiotics on Functional Abdominal Pain Disorders (FAPD) in Children: Randomized Clinical Trial (RCT)

TypeinterventionalSponsorUniversidad de ColimaRan2024 to 2025Enrolled82ConditionsFunctional Abdominal Pain Syndrome, Functional Gastrointestinal Disorders, Irritable Bowel Syndrome Variant of ChildhoodArmsTrimebutine, Lactobacillus rhamnosus, Placebo
NCT06417671 nacompletednot on this mapstarted 2024, after this paper: background citation

The Effect of Postbiotics Supplementation on Exercise-induced Oxidative Stress.

TypeinterventionalSponsorUniversity of ThessalyRan2024 to 2024Enrolled16ConditionsPostbiotics SupplementArmsPostbiotics supplementation, Placebo supplementation
NCT06423001 naunknown statusnot on this mapstarted 2024, after this paper: background citation

A Randomized, Cross-over, Placebo-Controlled, Double-Blind Clinical Trial on the Efficacy and Safety of Oral Administration of Postibiotic by FOS Fermentation From Lactobacillus Paracasei in the Treatment of Irritable Bowel Syndrome.

TypeinterventionalSponsorIstituto Clinico HumanitasRan2024 to 2026Enrolled36ConditionsIBS - Irritable Bowel SyndromeArmsPostbiotiX Slowing 4 g sachets PostbiotiX Slowing is a food supplement based on Fermented FOS from Lactobacillus paracasei CNCM I-5220.
NCT07278024 nacompletednot on this mapstarted 2025, after this paper: background citation

To Investigate the Effect of Postbiotic Intervention on Vaginal Microbiota in Infertile Women

TypeinterventionalSponsorKaohsiung Veterans General Hospital.Ran2025 to 2025Enrolled15ConditionsInfertile Women Undergoing IVF or ICSIArmspostbiotics
NCT07758933 phase1 / phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Prospective Study on the Safety of the Postbiotic Lactobacillus LB (Lactéol®) in Immuocompromised Pediatric Patients With Diarrhoeal Disease Treated at the Federico Gómez Children's Hospital of Mexico.

TypeinterventionalSponsorHospital Infantil de Mexico Federico GomezRan2026 to 2026Enrolled30ConditionsDiarrheaArmsLactobacillus LB
3 · Its place in the literature

Who cites it

1,208 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Beyond Probiotics: Postbiotics for Healthy Aquaculture.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  17. Review
  18. Review
  19. Review
  20. Review

1,148 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Seppo SalminenFunctional Foods Forum, Faculty of Medicine, University of Turku, Turku, Finland. sepsal@utu.fi.ORCID http://orcid.org/0000-0002-9737-7642
Maria Carmen ColladoInstitute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), Valencia, Spain.
Akihito EndoDepartment of Food, Aroma and Cosmetic Chemistry, Faculty of Bioindustry, Tokyo University of Agriculture, Hokkaido, Japan.ORCID http://orcid.org/0000-0002-7108-1202
Colin HillSchool of Microbiology, University College Cork, Cork, Ireland.ORCID http://orcid.org/0000-0002-8527-1445
Sarah LebeerDepartment of Bioscience Engineering, University of Antwerp, Antwerp, Belgium.
Eamonn M M QuigleyDivision of Gastroenterology and Hepatology, Lynda K and David M Underwood Center for Digestive Disorders, Houston Methodist Hospital and Weill Cornell Medical College, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4151-7180
Mary Ellen SandersInternational Scientific Association for Probiotics and Prebiotics, Centennial, CO, USA.ORCID http://orcid.org/0000-0001-6321-3423
Raanan ShamirInstitute of Pediatric Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Petach Tikva, Israel.
Jonathan R SwannSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Hania SzajewskaDepartment of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-4596-2874
Gabriel VinderolaInstituto de Lactología Industrial (CONICET-UNL), Faculty of Chemical Engineering, National University of Litoral, Santa Fe, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2019, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened a panel of experts specializing in nutrition, microbial physiology, gastroenterology, paediatrics, food science and microbiology to review the definition and scope of postbiotics. The term 'postbiotics' is increasingly found in the scientific literature and on commercial products, yet is inconsistently used and lacks a clear definition. The purpose of this panel was to consider the scientific, commercial and regulatory parameters encompassing this emerging term, propose a useful definition and thereby establish a foundation for future developments. The panel defined a postbiotic as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". Effective postbiotics must contain inactivated microbial cells or cell components, with or without metabolites, that contribute to observed health benefits. The panel also discussed existing evidence of health-promoting effects of postbiotics, potential mechanisms of action, levels of evidence required to meet the stated definition, safety and implications for stakeholders. The panel determined that a definition of postbiotics is useful so that scientists, clinical triallists, industry, regulators and consumers have common ground for future activity in this area. A generally accepted definition will hopefully lead to regulatory clarity and promote innovation and the development of new postbiotic products.

Indexed as

PrebioticsProbioticsConsensus Statements as TopicHumansSocieties, ScientificPrebiotics

Identifiers

PMID33948025
PMCPMC8387231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.